Compared to Cluster B, we found that Cluster A was markedly associated with early pathological stage (P < 0.001), left-sided CRC (P < 0.01), without BRAF mutations (P < 0.001), and low risk of recurrence (P < 0.001, Figure 2E). This evidence concerns the gene BRAF and colorectal carcinoma.